» Articles » PMID: 34881375

Suspension of Proactive Recommendations for HPV Vaccination Has Led to a Significant Increase in HPV Infection Rates in Young Japanese Women: Real-world Data

Overview
Date 2021 Dec 9
PMID 34881375
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Effect of information awareness on attitudes toward human papillomavirus vaccination intentions in Japan.

Takahashi T, Kinoshita T, Shigemi D, Imanishi Y, Sakamoto M, Ichimiya M Vaccine X. 2025; 22():100599.

PMID: 39802325 PMC: 11719379. DOI: 10.1016/j.jvacx.2024.100599.


Information-seeking Behavior of Iranian Young Adults (18-28 Years Old) Regarding HPV on Social Media: A Preventive Approach to HPV.

Latifi M, Alishan Karami N, Allahbakhshian L, Aghaesmaeili N, Tehrani H Int J Prev Med. 2024; 15:41.

PMID: 39381357 PMC: 11460987. DOI: 10.4103/ijpvm.ijpvm_337_23.


Questionnaire survey on cervical cancer screening and HPV awareness among patients at a local cancer center in Japan.

Nakamura K, Kigure K, Nishimura T, Yamashita S BMC Womens Health. 2024; 24(1):402.

PMID: 39014425 PMC: 11251239. DOI: 10.1186/s12905-024-03256-z.


Human Papillomavirus Vaccination by Birth Fiscal Year in Japan.

Yagi A, Ueda Y, Oka E, Nakagawa S, Kimura T JAMA Netw Open. 2024; 7(7):e2422513.

PMID: 39012629 PMC: 11252895. DOI: 10.1001/jamanetworkopen.2024.22513.


Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.

Phongsamart W, Lou P, Sukarom I, Wu Y, Zaidi O, Du F Hum Vaccin Immunother. 2024; 20(1):2362449.

PMID: 38925146 PMC: 11210899. DOI: 10.1080/21645515.2024.2362449.


References
1.
Ueda Y, Yagi A, Ikeda S, Enomoto T, Kimura T . Beyond resumption of the Japanese Government's recommendation of the HPV vaccine. Lancet Oncol. 2018; 19(12):1563-1564. DOI: 10.1016/S1470-2045(18)30573-4. View

2.
Simms K, Hanley S, Smith M, Keane A, Canfell K . Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. Lancet Public Health. 2020; 5(4):e223-e234. DOI: 10.1016/S2468-2667(20)30010-4. View

3.
Sekine M, Yamaguchi M, Kudo R, Hanley S, Hara M, Adachi S . Epidemiologic Profile of Type-Specific Human Papillomavirus Infection after Initiation of HPV Vaccination. Vaccines (Basel). 2020; 8(3). PMC: 7563721. DOI: 10.3390/vaccines8030425. View

4.
Nakagawa S, Ueda Y, Yagi A, Ikeda S, Hiramatsu K, Kimura T . Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan. Cancer Sci. 2020; 111(6):2156-2162. PMC: 7293087. DOI: 10.1111/cas.14406. View

5.
Tanaka Y, Ueda Y, Egawa-Takata T, Yagi A, Yoshino K, Kimura T . Outcomes for girls without HPV vaccination in Japan. Lancet Oncol. 2016; 17(7):868-869. DOI: 10.1016/S1470-2045(16)00147-9. View